Kuroda Naoki, Ueshima Satoshi, Sato Tomoaki, Kobiki Eriko, Kawasaki Yoichi, Matsunaga Hisashi, Nakura Hironori, Sendo Toshiaki
Okayama University, 1-1-1 Tsushima-naka, Okayama 700-8530, Japan.
Yakugaku Zasshi. 2012;132(1):125-33. doi: 10.1248/yakushi.132.125.
To clarify whether the new Japanese glomerular filtration rate (eGFR) equation was able to accurately determine the initial and individualized dosage adjustment concentrations of vancomycin (VCM), the predictive performance for VCM concentrations using the eGFR and Cockcroft-Gault (CG) equations was compared. Data were retrospectively collected from clinical records of 90 patients with MRSA infection whose trough and peak VCM concentrations had been determined. The predicted VCM initial and individualized dosage adjustment concentrations were performed with the 2-compartment linear model using pharmacokinetic parameter means and their individual values via Bayesian estimation, respectively. The prediction error (PE) and its absolute value (APE) between the observed and predicted VCM concentrations were calculated as indices of bias and accuracy in predictive performance, respectively. In the initial dosage adjustment of VCM, the PE value, calculated with the eGFR equation in trough and peak VCM concentrations of patients whose BMI were 18.5 kg/m(2) and higher, was significantly smaller than that calculated with the CG equation. In particular, both PE and APE values obtained from the eGFR calculated concentrations from nonelderly patients (younger than 65 years old) were significantly improved compared with those from the CG equation. In the individualized dosage adjustment of VCM, the eGFR equation gave a significantly smaller PE value in nonelderly patients' trough concentrations than the CG equation. These findings provide useful information for adjusting the VCM dosage to achieve optimal therapeutic efficacy in patients with MRSA infection.
为了阐明新的日本肾小球滤过率(eGFR)方程是否能够准确确定万古霉素(VCM)的初始及个体化剂量调整浓度,对使用eGFR方程和Cockcroft-Gault(CG)方程预测VCM浓度的性能进行了比较。回顾性收集了90例已测定VCM谷浓度和峰浓度的耐甲氧西林金黄色葡萄球菌(MRSA)感染患者的临床记录数据。分别通过贝叶斯估计,使用药代动力学参数均值及其个体值,采用二室线性模型预测VCM的初始及个体化剂量调整浓度。计算观察到的和预测的VCM浓度之间的预测误差(PE)及其绝对值(APE),分别作为预测性能偏差和准确性的指标。在VCM的初始剂量调整中,对于BMI为18.5kg/m²及以上患者的VCM谷浓度和峰浓度,使用eGFR方程计算的PE值显著小于使用CG方程计算的值。特别是,与CG方程相比,从非老年患者(年龄小于65岁)的eGFR计算浓度获得的PE和APE值均有显著改善。在VCM的个体化剂量调整中,eGFR方程在非老年患者的谷浓度中给出的PE值比CG方程显著更小。这些发现为调整VCM剂量以在MRSA感染患者中实现最佳治疗效果提供了有用信息。